Loading
₹2,500.00
0.000.00%today
Market closed · 7 Oct, 3:30 pm
+0.78%over 1 year
Today's range
₹2,480.10₹2,530.00
52-week range
₹1,909.70₹2,642.00
Revenue and net profit in ₹ crore, consolidated where the company reports both.
| Year | Revenue | Net profit | Margin | EPS (₹) |
|---|---|---|---|---|
| FY26 | 14,278 | 1,913 | 13.4% | 46.28 |
| FY25 | 12,207 | 1,991 | 16.3% | 49.19 |
| FY24 | 10,259 | 1,913 | 18.6% | 47.68 |
| FY23 | 8,749 | 1,282 | 14.7% | 32.00 |
As of Jun 2026, as a share of all the company's shares.
| Holder | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 72.63% | 72.66% | 72.66% | 72.67% |
| FIIs | 9.45% | 10.24% | 11.34% | 12.84% |
| DIIs | 15.39% | 14.46% | 13.25% | 11.92% |
| of which mutual funds | 10.87% | 10.36% | 9.30% | 7.78% |
| Public | 2.53% | 2.64% | 2.75% | 2.57% |
From the company's quarterly filings with NSE. FIIs are foreign institutions; DIIs are Indian ones such as mutual funds, insurers and banks.
Healthcare companies in the Nifty 500 closest in size.
| Company | Price (₹) | Change | Market cap (₹ cr) |
|---|---|---|---|
| Zydus Lifesciences Ltd.ZYDUSLIFE | 1,153.00 | −0.56% | 1,15,012 |
| Apollo Hospitals Enterprise Ltd.APOLLOHOSP | 7,917.00 | +0.03% | 1,13,834 |
| Laurus Labs Ltd.LAURUSLABS | 2,052.80 | +0.14% | 1,10,915 |
| Cipla Ltd.CIPLA | 1,327.20 | −0.97% | 1,07,221 |
| Mankind Pharma Ltd.MANKIND · this stock | 2,500.00 | 0.00% | 1,03,261 |
| Dr. Reddy's Laboratories Ltd.DRREDDY | 1,203.80 | −0.35% | 1,00,476 |
| Aurobindo Pharma Ltd.AUROPHARMA | 1,682.00 | −0.64% | 96,779 |
Price and volume from NSE; key figures and results from Yahoo Finance; shareholding and corporate actions from the company's NSE filings. Figures can run behind the exchange. For information only, not a recommendation to invest.